EUVIMEDEUVIMED entdecken
Editorial

Lenacapavir: a giant step forward in HIV prevention—but a missed opportunity for achieving equity and access

Gavin Yamey, Shingai Machingaidze

BMJ · 2024

DOI: 10.1136/bmj.q2254 ↗

Kurz gefasst

Editorial in der Zeitschrift BMJ, 2024. Verfasst von Gavin Yamey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University. Hauptthemen laut MEDLINE: HIV Infections, Health Services Accessibility. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHealth Services AccessibilityHumansQuinolonesAnti-HIV AgentsPre-Exposure ProphylaxisHealth Equity

Substanzen

QuinolonesAnti-HIV Agents

Autor:innen und Institutionen

  • Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University.
  • South Africa.

Zitieren

APA

Yamey, G., & Machingaidze, S. (2024). Lenacapavir: a giant step forward in HIV prevention—but a missed opportunity for achieving equity and access. BMJ. https://doi.org/10.1136/bmj.q2254

Vancouver

Yamey G, Machingaidze S. Lenacapavir: a giant step forward in HIV prevention—but a missed opportunity for achieving equity and access. BMJ. 2024. doi:10.1136/bmj.q2254

BibTeX
@article{Yamey2024,
  author = {Yamey, Gavin and Machingaidze, Shingai},
  title = {Lenacapavir: a giant step forward in HIV prevention—but a missed opportunity for achieving equity and access},
  journal = {BMJ},
  year = {2024},
  doi = {10.1136/bmj.q2254}
}
Kostenlos starten →